Ongoing peak body recognition for PSA
The Pharmaceutical Society of Australia (PSA) has welcomed today’s Federal Government recognition of the work PSA does for all pharmacists in Australia by continuing...
From tea leaves to the world
Despite its flaws, theophylline remains available in Australia.
Are antibiotics courses for common infections too long?
In the fight against antibiotic resistance, shorter courses of antibiotics are now recommended for patients with common infections, but how short is long enough?
The...
New guidelines establish safe opioid deprescribing practices
Creating a tailored, individualised approach is the key to helping patients safely deprescribe from opioids.
Sustainable pharmacy practice is the order of the day
A resounding theme at the FIP World Congress of Pharmacy and Pharmaceutical Sciences in Brisbane is the need for action on climate change.
Making medicine safer for people with intellectual and developmental disability
Pharmacists have the skills and capacity to support people with intellectual and developmental disabilities (IDD), but often don’t know where to start.
Speak to the...
